Stereotactic Body Radiotherapy for Primary Lung Cancer at a Dose of 50 Gy Total in Five Fractions to the Periphery of the Planning Target Volume Calculated Using a Superposition Algorithm

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 442-448

  Takeda, Atsuya ^a,b   Sanuki, Naoko ^a   Kunieda, Etsuo ^b,c   Ohashi, Toshio ^c   Oku, Yohei ^c   Takeda, Toshiaki ^b   Shigematsu, Naoyuki ^c   Kubo, Atsushi ^c  

^a OFUNA CHUO HOSPITAL   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Lung cancer; Stereotactic body radiotherapy; Superposition algorithm

Indexed keywords

BIOLOGICAL ORGANS; DIAGNOSTIC RADIOGRAPHY; DISEASE CONTROL; MEDICAL IMAGING; RADIOTHERAPY; TARGETS; TOMOGRAPHY; TUMORS;

ACUTE TOXICITIES; CLINICAL OUTCOMES; CURATIVE INTENTS; FLUORODEOXYGLUCOSE; LOCAL CONTROLS; LUNG CANCER; OVERALL SURVIVAL RATES; PERFORMANCE STATUSES; PLANNING TARGET VOLUMES; POSITRON EMISSIONS; RADIATION PNEUMONINITIDES; STEREOTACTIC BODY RADIOTHERAPY; SUPERPOSITION ALGORITHM; TUMOR MARKERS; WORLD HEALTH ORGANIZATIONS;

POSITRON EMISSION TOMOGRAPHY;

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; FLUORODEOXYGLUCOSE; TUMOR MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; BACTERIAL PNEUMONIA; CANCER STAGING; CYTOPATHOLOGY; DISEASE CONTROL; DISEASE FREE SURVIVAL; DOSIMETRY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; SUPERPOSITION ALGORITHM; TARGET ORGAN; THORAX RADIOGRAPHY; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION PNEUMONITIS; RADIOSURGERY; RELATIVE BIOLOGICAL EFFECTIVENESS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 58149357271     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.043     Document Type: Article

References (35)

1. Radiation Therapy Study Group. Japan clinical oncology group: Study protocol 0403. Available at https://member.jcog.jp/member/protocol/group12_rtsg/JCOG0403/0403ver1.4/ProtocolJCOG0403v1_4.pdf. Accessed August 19, 2008.
2. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
3. Miften M., Wiesmeyer M., Monthofer S., et al. Implementation of FFT convolution and multigrid superposition models in the FOCUS RTP system. Phys Med Biol 45 (2000) 817-833
4. Takeda T., Takeda A., Kunieda E., et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: Serial changes on CT. AJR Am J Roentgenol 182 (2004) 1123-1128
5. Takeda A., Kunieda E., Shigematsu N., et al. Small lung tumors: Long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-Initial findings. Radiology 237 (2005) 295-300
6. Takeda A., Kunieda E., Takeda T., et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 70 (2007) 1057-1065
7. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 (2006) 787-795
8. Onimaru R., Fujino M., Yamazaki K., et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 374-381
9. Koto M., Takai Y., Ogawa Y., et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85 (2007) 429-434
10. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
11. Bradley J.D., Nofal A.N., El Naqa I.M., et al. Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer. Radiother Oncol 81 (2006) 264-268
12. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
13. Wong J.R., Grimm L., Uematsu M., et al. Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: Prostate movements and dosimetric considerations. Int J Radiat Oncol Biol Phys 61 (2005) 561-569
14. Nishio T., Kunieda E., Shirato H., et al. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol 51 (2006) 5409-5417
15. Fogliata A., Vanetti E., Albers D., et al. On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: Comparison with Monte Carlo calculations. Phys Med Biol 52 (2007) 1363-1385
16. Haedinger U., Krieger T., Flentje M., et al. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys 61 (2005) 239-249
17. Kunieda E. Variation of dose distribution of stereotactic radiotherapy for small-volume lung tumors under different respiratory conditions. Phys Med (2008) In press
18. Miften M., Wiesmeyer M., Kapur A., et al. Comparison of RTP dose distributions in heterogeneous phantoms with the BEAM Monte Carlo simulation system. J Appl Clin Med Phys 2 (2001) 21-31
19. O'Connor J.E. The variation of scattered x-rays with density in an irradiated body. Phys Med Biol 1 (1957) 352-369
20. Engelsman M., Damen E.M., Koken P.W., et al. Impact of simple tissue inhomogeneity correction algorithms on conformal radiotherapy of lung tumours. Radiother Oncol 60 (2001) 299-309
21. Aoki T., Nagata Y., Negoro Y., et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 230 (2004) 101-108
22. Kimura T., Matsuura K., Murakami Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers?. Int J Radiat Oncol Biol Phys 66 (2006) 483-491
23. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
24. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
25. Wu Y., Huang Z.F., Wang S.Y., et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6
26. Izbicki J.R., Passlick B., Pantel K., et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: Results of a prospective randomized trial. Ann Surg 227 (1998) 138-144
27. Izbicki J.R., Thetter O., Habekost M., et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 81 (1994) 229-235
28. Veronesi U., and Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47 (1981) 170-175
29. Veronesi U., Marubini E., Mariani L., et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-Year results of a randomised trial. Eur J Cancer 35 (1999) 1320-1325
30. Shim S.S., Lee K.S., Kim B.T., et al. Non-small cell lung cancer: Prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236 (2005) 1011-1019
31. Konaka C., Ikeda N., Hiyoshi T., et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: Proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer 21 (1998) 185-191
32. Yau G., Lock M., and Rodrigues G. Systematic review of baseline low-dose CT lung cancer screening. Lung Cancer 58 (2007) 161-170
33. Lagerwaard F.J., Haasbeek C.J., Smit E.F., et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 685-692
34. Swensen S.J., Silverstein M.D., Edell E.S., et al. Solitary pulmonary nodules: Clinical prediction model versus physicians. Mayo Clin Proc 74 (1999) 319-329
35. 18F-fluorodeoxyglucose positron emission tomography. Chest 128 (2005) 2490-2496